Home | Welcome to Contract Pharma   
Last Updated Friday, November 28 2014
Print

Breaking News

April 3, 2014
Hedrick to succeed Calhoun  Read More »
April 3, 2014
Engelhardt brings 20 years of experience  Read More »
April 3, 2014
Nature and complexity of drug candidates drives increase in use of dedicated supply chain providers  Read More »
April 3, 2014
Launches QIAxpert instrument and CLC Cancer Research Workbench  Read More »
April 3, 2014
Diabetes drug employs Novozymes VELTIS extension technology  Read More »
April 3, 2014
Prizer's use of tranSMART, an open source data management system, allows it to connect genomic, clinical trial and patient data to spot potential niche opportunities for new drugs. Its work won it Innovationweek's top "Elite 100" prize for IT innovation.   Read More »
April 3, 2014
Kemwell expands lyophilization capacity  Read More »
April 3, 2014
Catalent Pharma Solutions has increased its minority investment in Redwood Bioscience. The decision was based on data generated by the SMARTag ADC platform, a precision protein-chemical engineering platform and novel toxin-linker technology developed…  Read More »
April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s…  Read More »
April 3, 2014
AMRI to Acquire Cedarburg Pharma  Read More »
April 2, 2014
Information Week awarded Merck for its innovative use of big data analytics and Hadoop, to improve vaccine manufacturing  Read More »
April 2, 2014
Chinese researchers are exploring potential patient risks from phthalate leaching out of metered-dose inhalers.  Read More »
April 2, 2014
According to research underway at Brazil's Oswaldo Cruz Foundation, Brazil has a $2.4-billion deficit in API production  Read More »
April 2, 2014
Japan's Ministry of Health, Labor and Welfare has approved Takeda's NDA for cell-cultured flu vaccine, using Baxter International's technology.  Read More »
April 2, 2014
CPDC to manufacture radiotherapy candidate for Phase II trials  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On